BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6622504)

  • 1. Quantitation of tolerance development after chronic oxotremorine treatment.
    Marks MJ; Artman LD; Collins AC
    Pharmacol Biochem Behav; 1983 Jul; 19(1):103-13. PubMed ID: 6622504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic influences on tolerance development with chronic oxotremorine infusion.
    Marks MJ; Romm E; Collins AC
    Pharmacol Biochem Behav; 1987 Aug; 27(4):723-32. PubMed ID: 3659096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-tolerance between muscarinic agonists: role of muscarinic receptors.
    Collins AC; Smolen TN; Smolen A; Medhurst LJ
    Pharmacol Biochem Behav; 1987 Jan; 26(1):173-82. PubMed ID: 3562489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic adaptations to chronic oxotremorine infusion.
    Marks MJ; Artman LD; Patinkin DM; Collins AC
    J Pharmacol Exp Ther; 1981 Aug; 218(2):337-43. PubMed ID: 7252834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential alterations of cholinergic muscarinic receptors during chronic and acute tolerance to organophosphorus insecticides.
    Costa LG; Schwab BW; Murphy SD
    Biochem Pharmacol; 1982 Nov; 31(21):3407-13. PubMed ID: 7150362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance, cross-tolerance, and receptors after chronic nicotine or oxotremorine.
    Marks MJ; Collins AC
    Pharmacol Biochem Behav; 1985 Feb; 22(2):283-91. PubMed ID: 3983219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic scopolamine treatment and brain cholinergic function.
    Marks MJ; O'Connor MF; Artman LD; Burch JB; Collins AC
    Pharmacol Biochem Behav; 1984 May; 20(5):771-7. PubMed ID: 6739517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of decreased numbers of muscarinic receptors from tolerance to DFP.
    Smolen TN; Smolen A; Collins AC
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1293-301. PubMed ID: 3809233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of chronic oxotremorine treatment on spatial learning and tolerance development in mice.
    Wehner JM; Upchurch M
    Pharmacol Biochem Behav; 1989 Feb; 32(2):543-51. PubMed ID: 2727016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.
    Daly JW; Gupta TH; Padgett WL; Pei XF
    J Med Chem; 2000 Jun; 43(13):2514-22. PubMed ID: 10891110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic receptor alterations as a mechanism of anticholinesterase tolerance.
    Schwab BW; Costa LG; Murphy SD
    Toxicol Appl Pharmacol; 1983 Oct; 71(1):14-23. PubMed ID: 6636179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.
    Lee W; Wolfe BB
    Mol Pharmacol; 1989 Nov; 36(5):749-57. PubMed ID: 2555673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species differences in diisopropylfluorophosphate-induced decreases in the number of brain nicotinic receptors.
    Van de Kamp JL; Collins AC
    Pharmacol Biochem Behav; 1992 May; 42(1):131-41. PubMed ID: 1528936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contraction and [3H]QNB binding in collagenase isolated fundic smooth muscle cells.
    Seidel ER; Johnson LR
    Am J Physiol; 1983 Aug; 245(2):G270-6. PubMed ID: 6881350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
    Martin MW; Smith MM; Harden TK
    J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo modulation of the number of muscarinic receptors in rat brain by cholinergic ligands.
    Ben-Barak J; Gazit H; Silman I; Dudai Y
    Eur J Pharmacol; 1981 Aug; 74(1):73-81. PubMed ID: 7318895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acetylethylcholine mustard on [3H]quinuclidinyl benzilate binding and acetylcholine release in rat brain synaptosomes.
    Meyer EM; Otero DH; Morgan E; Marchand S; Baker SP
    J Neurochem; 1987 Feb; 48(2):477-82. PubMed ID: 3794717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo regulation of muscarinic cholinergic receptors in embryonic chick brain.
    Meyer MR; Gainer MW; Nathanson NM
    Mol Pharmacol; 1982 Mar; 21(2):280-6. PubMed ID: 7099136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of sensitivity to oxotremorine and muscarinic receptors in LS and SS mice.
    Collins AC; Campbell SM; Romm E; Marks MJ
    Alcohol Clin Exp Res; 1990 Aug; 14(4):605-15. PubMed ID: 2221290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.